If you need more lookups,
subscriptions start at $34 USD/month.
Chris Hendriksz Location
Burley in Wharfedale, England, GB
Chris Hendriksz Work
Chief Medical Officer and Co- founder @ (April 2025 - Present)
Chief Community Impact Officer @ (November 2024 - Present)
extraordinary Professor Human Metabolomics @ (January 2020 - Present)
Professor @ (November 2014 - Present)
Medical Consultant @ (April 2024 - July 2026)
Fractional Chief Medical Officer @ (February 2019 - December 2024)
Global Clinical Development Lead , Rare Diseases,IEM and Innovative Pharmaceuticals @ Nestlé Health Science (December 2020 - March 2024)
Chief Executive Director @ (August 2016 - October 2020)
CEO @ (December 2015 - October 2020)
Chief Executive Officer @ (December 2015 - October 2020)
Consultant in Transitional Metabolic Medicine @ (April 2012 - March 2018)
Clinical Lead @ (April 2012 - July 2016)
Chair for Clinical Studies Group for Inherited Metabolic Disorders @ Medicines for Children Research Network (June 2009 - March 2014)
Director for Lysosomal Storage Disorders @ (April 2007 - March 2012)
Consultant in Inherited Metabolic Disorders @ (July 2004 - March 2012)
Specialist Registrar in Paediatric Metabolic Disease @ Central Manchester & Manchester Children's Foundation Trust (March 2002 - June 2004)
Chris Hendriksz Education
Royal College of Paediatrics and Child Health
FRCPCH (Paediatrics/ Sub specialty Inborn errors of metabolism)
1997-2000
University of Pretoria
M Sc (Sports Medicine)
1993-1995
University of Pretoria
MB ChB (Medicine)
1979-1984
Chris Hendriksz Skills
Biotechnology
Brain Research
Business Continuity Planning
CCT
CRO
CTMS
Cancer
Cardiology
Clinical Consulting
Clinical Development
Clinical Governance
Clinical Research
Clinical Research & Drug Development
Clinical Trials
Communication
Critical Care Transport (CCT)
Data-driven Decision Making
Diabetes
Emergency Medicine
GCP
GMC
Health Promotion
Health Services Research
Healthcare
Healthcare Innovation & AI Integration
Healthcare Management
Hematology
Hospitals
Immunology
Infectious Diseases
Informatics
Internal Medicine
Leadership
Life Sciences
Lifesciences
Medical Affairs
Medical Devices
Medical Education
Medical Writing
Medicine
Nephrology
Neurology
Neuroscience
Oncology
Patient Advocacy
Patient Care
Pediatrics
Pharmaceutical Industry
Pharmaceuticals
Pharmacology
Pharmacovigilance
Public Health
Rare Disease Strategy & Leadership
Rare Diseases
Research
Service Evaluation
Stakeholder Engagement & Advocacy
Therapeutic Areas
Treatment
Public Speaking
Sales
Strategic Planning
Chris Hendriksz Summary
Chris Hendriksz, based in Burley in Wharfedale, England, GB, is currently a Chief Medical Officer and Co- founder at Decentra Health. Chris Hendriksz brings experience from previous roles at A Rare Cause, North-West University / Noordwes-Universiteit, University of Pretoria and FYMCA MEDICAL LTD. Chris Hendriksz holds a 1997 - 2000 FRCPCH in Paediatrics/ Sub specialty Inborn errors of metabolism @ Royal College of Paediatrics and Child Health. With a robust skill set that includes Biotechnology, Brain Research, Business Continuity Planning, CCT, CRO and more. Chris Hendriksz has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chris Hendriksz?
Find contact details for 700 million professionals.